Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Koopmanschap

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Health Policy (Amsterdam, Netherlands)|October 28, 1999
Productivity losses without absence: measurement validation and empirical evidenceW B Brouwer, M A Koopmanschap, F F Rutten
Health Economics|November 14, 1997
Productivity costs in cost-effectiveness analysis: numerator or denominator: a further discussionW B Brouwer, M A Koopmanschap, F F Rutten
European Journal of Cancer (Oxford, England : 1990)|September 1, 1995
The management of cervical intra-epithelial neoplasia (CIN): extensiveness and costs in The NetherlandsM van Ballegooijen, M A Koopmanschap, J D Habbema
International Journal of Technology Assessment in Health Care|October 22, 1998
Patient and informal caregiver time in cost-effectiveness analysis. A response to the recommendations of the Washington PanelW B Brouwer, M A Koopmanschap, F F Rutten
Nederlands Tijdschrift Voor Geneeskunde|November 5, 1994
[Costs of intensive care in The Netherlands]C N Hilgeman, M A Koopmanschap, F F Rutten
Health Economics|May 1, 1997
Productivity costs measurement through quality of life? A response to the recommendation of the Washington PanelW B Brouwer, M A Koopmanschap, F F Rutten
Health Policy (Amsterdam, Netherlands)|September 12, 2001
Analysis of costs and cost-effectiveness in multinational trialsM A Koopmanschap, K C Touw, F F Rutten
Social Science & Medicine (1982)|October 1, 1992
Costs of home care for advanced breast and cervical cancer in relation to cost-effectiveness of screeningM A Koopmanschap, B M van Ineveld, T E Miltenburg
Clinical Pharmacology and Therapeutics|April 4, 2013
The cost-effectiveness of periodic safety update reports for biologicals in EuropeJ C Bouvy, H C Ebbers, H Schellekens, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Current and future costs of cancerM A Koopmanschap, L van Roijen, L Bonneux, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Health Policy (Amsterdam, Netherlands)|October 28, 1999
Productivity losses without absence: measurement validation and empirical evidenceW B Brouwer, M A Koopmanschap, F F Rutten
Health Economics|November 14, 1997
Productivity costs in cost-effectiveness analysis: numerator or denominator: a further discussionW B Brouwer, M A Koopmanschap, F F Rutten
European Journal of Cancer (Oxford, England : 1990)|September 1, 1995
The management of cervical intra-epithelial neoplasia (CIN): extensiveness and costs in The NetherlandsM van Ballegooijen, M A Koopmanschap, J D Habbema
International Journal of Technology Assessment in Health Care|October 22, 1998
Patient and informal caregiver time in cost-effectiveness analysis. A response to the recommendations of the Washington PanelW B Brouwer, M A Koopmanschap, F F Rutten
Nederlands Tijdschrift Voor Geneeskunde|November 5, 1994
[Costs of intensive care in The Netherlands]C N Hilgeman, M A Koopmanschap, F F Rutten
Health Economics|May 1, 1997
Productivity costs measurement through quality of life? A response to the recommendation of the Washington PanelW B Brouwer, M A Koopmanschap, F F Rutten
Health Policy (Amsterdam, Netherlands)|September 12, 2001
Analysis of costs and cost-effectiveness in multinational trialsM A Koopmanschap, K C Touw, F F Rutten
Social Science & Medicine (1982)|October 1, 1992
Costs of home care for advanced breast and cervical cancer in relation to cost-effectiveness of screeningM A Koopmanschap, B M van Ineveld, T E Miltenburg
Clinical Pharmacology and Therapeutics|April 4, 2013
The cost-effectiveness of periodic safety update reports for biologicals in EuropeJ C Bouvy, H C Ebbers, H Schellekens, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Current and future costs of cancerM A Koopmanschap, L van Roijen, L Bonneux, et al.
Pageof 6